BRIEF published on 01/14/2025 at 14:35, 1 year 9 months ago Quantum BioPharma Ltd. commence à négocier sur le marché en amont Biopharmacie Quantique Double Cotation Investisseurs Mondiaux Négoce En Amont Entreprise Biopharmaceutique
PRESS RELEASE published on 01/14/2025 at 14:30, 1 year 9 months ago Quantum Biopharma Ltd. Now Trading on Upstream Under QNTM Quantum BioPharma Ltd. dual lists on Upstream's global securities trading app, providing international investors streamlined access to Quantum shares. Details at https://www.quantumbiopharma.com/investors Investors Dual Listing Quantum BioPharma Upstream Global Securities Trading
BRIEF published on 01/07/2025 at 14:35, 1 year 9 months ago Quantum Biopharma Ltd. va s'inscrire en double sur le marché en amont Plateforme De Trading Biopharmacie Quantique Double Annonce Marché En Amont Investisseurs Mondiaux
BRIEF published on 01/07/2025 at 14:35, 1 year 9 months ago Quantum Biopharma Ltd. to Dual List on Upstream Market Dual Listing Global Investors Trading Platform Quantum BioPharma Upstream Market
PRESS RELEASE published on 01/07/2025 at 14:30, 1 year 9 months ago Quantum Biopharma Ltd. Approved to Dual List on Upstream Quantum BioPharma dual lists on Upstream for global trading on January 14th, expanding investor opportunity. Details on trading and shareholder instructions provided Dual Listing Quantum BioPharma Investor Opportunity Upstream Global Trading
BRIEF published on 12/21/2024 at 01:35, 1 year 10 months ago Quantum BioPharma conclut la deuxième tranche de son offre Biopharmacie Quantique Unités D'obligations NASDAQ:QNTM Deuxième Tranche Investissement Biopharmaceutique
BRIEF published on 12/21/2024 at 01:35, 1 year 10 months ago Quantum BioPharma Concludes Second Tranche of Offering Quantum BioPharma Debenture Units Second Tranche Biopharmaceutical Investment NASDAQ:QNTM
PRESS RELEASE published on 12/21/2024 at 01:30, 1 year 10 months ago Quantum Biopharma Announces Closing of Second Tranche Quantum BioPharma announces closing of Second Tranche of offering, issuing 500 Debenture Units for $500,000 to advance business model and working capital Working Capital Business Model Quantum BioPharma Debenture Units Second Tranche
BRIEF published on 12/20/2024 at 15:20, 1 year 10 months ago Quantum BioPharma Embraces Cryptocurrency for Treasury Diversification Financial Compliance Strategic Diversification Quantum BioPharma Bitcoin Treasury Cryptocurrency Investment
BRIEF published on 12/20/2024 at 15:20, 1 year 10 months ago Quantum BioPharma adopte la crypto-monnaie pour diversifier sa trésorerie Conformité Financière Diversification Stratégique Biopharmacie Quantique Trésor Bitcoin Investissement En Crypto-monnaie
Published on 10/26/2026 at 13:30, 31 minutes ago Stabilis Solutions Announces Third Quarter 2026 Conference Call and Webcast Date
Published on 10/26/2026 at 13:00, 1 hour 1 minute ago BTU Commences Initial Drill Program on Hubcap Project Adjacent to RPX in Wawa
Published on 10/26/2026 at 12:30, 1 hour 31 minutes ago Longview Capital Announces Voluntary TSXV Delisting
Published on 10/26/2026 at 12:30, 1 hour 31 minutes ago Empress Appoints Chief Investment Officer and Strengthens Senior Leadership Team
Published on 10/26/2026 at 13:52, 8 minutes ago Correction of a release from 26.10.2026 08:00 GMT/BST - Official List Notice
Published on 10/26/2026 at 13:35, 25 minutes ago Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 6.05 Million Tokens, and Total Crypto and Total Cash & Marketable Securities Holdings of $15 Billion
Published on 10/26/2026 at 12:05, 1 hour 55 minutes ago EQS-Adhoc: Notification regarding the selection of an auditor of Starcom Holding AD for 2026
Published on 10/26/2026 at 12:00, 2 hours 1 minute ago OHB acquires stake in MediaMobil to strengthen satellite communications capabilities
Published on 10/26/2026 at 11:27, 2 hours 34 minutes ago 261026 BENETEAU Transactions sur actions propres
Published on 10/26/2026 at 07:30, 6 hours 31 minutes ago EURAZEO’S SUPERVISORY BOARD APPOINTS CHRISTOPHE BAVIÈRE AS CHAIRMAN OF THE EXECUTIVE BOARD AND CEO
Published on 10/26/2026 at 07:30, 6 hours 31 minutes ago LE CONSEIL DE SURVEILLANCE D’EURAZEO NOMME M. CHRISTOPHE BAVIERE PRESIDENT DU DIRECTOIRE
Published on 10/23/2026 at 20:33, 2 days 17 hours ago Déclaration hebdomadaire d'opérations effectuées du 19 au 23 octobre 2026
Published on 10/23/2026 at 20:33, 2 days 17 hours ago Disclosure of transactions in own shares from October 19 to October 23, 2026
